Archive - February 2018
Mayo Clinic CEO Noseworthy to retire
USV sterile injectables plant overcomes issues that resulted in warning letter
NICE recommends thyroid cancer drug trio for NHS use
Lilly drops Hanmi-partnered arthritis drug
Study weighs risks and benefits of phase I trials in pediatric cancer
Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel
Shaky mid-stage data won’t halt Celgene’s plans for Otezla
Shire, Microsoft and EURORDIS form rare disease alliance